Allakos Inc.
NASDAQ: ALLK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Robert Alexander
- Employees
- 131
- Headquarters
- San Carlos, United States
- IPO year
- 2018
- Market cap
- $29.7M
- Website
- https://www.allakos.com
Loading ALLK…
Loading profile data…Frequently asked questions about ALLK
What does Allakos Inc. (ALLK) do?
Allakos Inc. is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing therapeutic agents. These treatments are designed to target specific immunomodulatory receptors on immune effector cells, addressing a spectrum of allergic, inflammatory, and proliferative conditions. The company's flagship investigational product is l...
Where does ALLK trade?
Allakos Inc. (ALLK) trades on the NASDAQ Global Select.
What sector is ALLK in?
Allakos Inc. (ALLK) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Allakos Inc.?
Robert Alexander is the chief executive officer of Allakos Inc. (ALLK).
Where is Allakos Inc. headquartered?
Allakos Inc. is headquartered in United States.
Does ALLK pay a dividend?
Allakos Inc. (ALLK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ALLK go public?
Allakos Inc. (ALLK) completed its initial public offering in 2018.